Page 2 - Sahm Nasseri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sahm nasseri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sahm Nasseri Today - Breaking & Trending Today

PYC Therapeutics Highlights Continued Progress of Ocular and CNS Pipeline Programs and U.S. Expansion in First Quarter Update


Share this article
Share this article
NEW YORK and PERTH, Australia, April 30, 2021 /PRNewswire/  PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced a first quarter update highlighting the progress of its development pipeline, growth of its U.S. operations and upcoming milestones.
PYC has had an exciting quarter of progress against our Company objectives. We have achieved continued validation of our PPMO technology in our lead candidate VP-001 for retinitis pigmentosa type 11, further development of our ocular pipeline as well as PYC s first set of preclinical data from our CNS discovery efforts demonstrating superior delivery of RNA therapeutic throughout the brain and spinal cord. The potential of our pioneering PPMO technology is vast and we look forward to advancing this technology to provide solutions for patients with inherited o ....

Western Australia , Michael Rosenblatt , Phosphorodiamidate Morpholino Oligomer , Kaggen Ausma , Sahm Nasseri , Leo Vartorella , Deborah Elson Matthew Deyoung , Glenn Noronha , Drug Administration , Executive Officer , Alan Tribe , Ocular Diseases , Investigational New Drug , Nervous System , Chief Development Officer , Chief Business Officer , Board Directors , Jason Haddock , West Coast , Adeno Associated Virus , Mol Ther Methods Clin , Global Burden , Disease Study , Pyc Therapeutics , மேற்கு ஆஸ்திரேலியா , மைக்கேல் ரோசன்ப்ளாட் ,

PYC Therapeutics Appoints U.S. Biopharma Executive Jason Haddock to its Board of Directors


Published: Mar 29, 2021
 
NEW YORK and PERTH, Australia, March 29, 2021 /PRNewswire/  PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced the appointment of Jason Haddock to its Board of Directors. Mr. Haddock brings more than two decades of financial, commercial and operational leadership experience in the biopharmaceutical industry, and currently serves as a Board Director of Codiak BioSciences, a biotech company developing precision exosome therapeutics.
Throughout his career, Mr. Haddock has held a variety of leadership roles at biopharma companies, overseeing finance, commercial and business development strategies in the U.S. and worldwide. Previously, he was Chief Financial Officer at Array Biopharma, where he was instrumental in developing a research, development and commercialization strategy that culminated in the successf ....

Western Australia , Codiak Biosciences , Sahm Nasseri , Asia Pacific , Bristol Myers Squibb , Washington University In St , Olin Business School , Illinois State University , Jason Haddock , Board Director , Chief Financial Officer , Array Biopharma , Executive Officer , Washington University , Olin Business , Cell Penetrating Peptides , Pyc Therapeutics Appoints Us Biopharma Executive Jason Haddock To Its Board Of Directors , மேற்கு ஆஸ்திரேலியா , ஆசியா பெஸிஃபிக் , பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் , வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் , ஒளின் வணிக பள்ளி , இல்லினாய்ஸ் நிலை பல்கலைக்கழகம் , ஜேசன் ஹேடாக் , பலகை இயக்குனர் , தலைமை நிதி அதிகாரி ,